136 related articles for article (PubMed ID: 1574541)
1. Drug-responsive symptoms during early neuroleptic treatment.
Mazure CM; Nelson JC; Jatlow PI; Bowers MB
Psychiatry Res; 1992 Feb; 41(2):147-54. PubMed ID: 1574541
[TBL] [Abstract][Full Text] [Related]
2. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
Mazure CM; Nelson JC; Jatlow PI; Bowers MB
Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
[TBL] [Abstract][Full Text] [Related]
3. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
Bowers MB; Mazure CM; Nelson JC; Jatlow PI
Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
[TBL] [Abstract][Full Text] [Related]
4. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB
J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431
[TBL] [Abstract][Full Text] [Related]
5. Psychotogenic drug use and neuroleptic response.
Bowers MB; Mazure CM; Nelson JC; Jatlow PI
Schizophr Bull; 1990; 16(1):81-5. PubMed ID: 1970670
[TBL] [Abstract][Full Text] [Related]
6. Acutely psychotic patients receiving high-dose haloperidol therapy.
Remington G; Pollock B; Voineskos G; Reed K; Coulter K
J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
[TBL] [Abstract][Full Text] [Related]
7. Effects of haloperidol on human plasma magnesium.
Jabotinsky-Rubin K; Durst R; Levitin LA; Moscovich DG; Silver H; Lerner J; Van Praag H; Gardner EL
J Psychiatr Res; 1993; 27(2):155-9. PubMed ID: 8366466
[TBL] [Abstract][Full Text] [Related]
8. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer HY
Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323
[TBL] [Abstract][Full Text] [Related]
9. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological treatment of delusional depression].
Amore M; Giordani L; Giorgetti G; Zazzeri N
Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.
Kramer MS; Vogel WH; DiJohnson C; Dewey DA; Sheves P; Cavicchia S; Little P; Schmidt R; Kimes I
Arch Gen Psychiatry; 1989 Oct; 46(10):922-8. PubMed ID: 2679483
[TBL] [Abstract][Full Text] [Related]
12. Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.
Baumann P; Eap CB; Zullino DF
J Nerv Ment Dis; 2001 Nov; 189(11):798-9. PubMed ID: 11758666
[No Abstract] [Full Text] [Related]
13. TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs.
Langer G; Resch F; Aschauer H; Keshavan MS; Koinig G; Schönbeck G; Dittrich R
Neuropsychobiology; 1984; 11(4):213-8. PubMed ID: 6436728
[TBL] [Abstract][Full Text] [Related]
14. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Casey E
Am J Psychiatry; 1988 Dec; 145(12):1532-7. PubMed ID: 3057924
[TBL] [Abstract][Full Text] [Related]
15. Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria.
Newcomer JW; Miller LS; Faustman WO; Wetzel MW; Vogler GP; Csernansky JG
Br J Psychiatry; 1994 Jun; 164(6):834-8. PubMed ID: 7952993
[TBL] [Abstract][Full Text] [Related]
16. Relationships between medication treatments and neuropsychological test performance in schizophrenia.
Sweeney JA; Keilp JG; Haas GL; Hill J; Weiden PJ
Psychiatry Res; 1991 Jun; 37(3):297-308. PubMed ID: 1679950
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
[TBL] [Abstract][Full Text] [Related]
18. Treatment of schizoaffective disorders.
Goodnick PJ; Meltzer HY
Schizophr Bull; 1984; 10(1):30-48. PubMed ID: 6142525
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of fluvoxamine increases serum concentrations of haloperidol.
Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S
J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690
[TBL] [Abstract][Full Text] [Related]
20. Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.
Balant-Gorgia AE; Eisele R; Balant L; Garrone G
Eur Arch Psychiatry Neurol Sci; 1984; 234(1):1-4. PubMed ID: 6489392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
